APOB and type 2 diabetes mellitus: Changes in postprandial lipoprotein metabolism after statins have been studied (114), and atorvastatin significantly reduced postprandial TG, TRL apoB48, VLDL, and IDL apoB100 levels in T2D patients with high TG levels (115).